S4.4.6.1-4. Engelfriet PM, Duffels MGJ, M ller T, et al. Pulmonary arte- rial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease. Heart. 2007;93:682 7. S4.4.6.1-5. Lowe BS, Therrien J, Ionescu-Ittu R, et al. Diagnosis of pulmonary hypertension in the congenital heart disease adult population im- pact on outcomes. J Am Coll Cardiol. 2011;58:538 46. S4.4.6.1-6. Manes A, Palazzini M, Leci E, et al. Current era survival of patients with pulmonary arterial hypertension associated with congen- ital heart disease: a comparison between clinical subgroups. Eur Heart J. 2014;35:716 24. S4.4.6.1-7. Gabriels C, De Meester P, Pasquet A, et al. A different view on predictors of pulmonary hypertension in secundum atrial septal defect. Int J Cardiol. 2014;176:833 40. S4.4.6.1-8. O Donnell C, Ruygrok PN, Whyte K, et al. Progressive pulmonary hypertension post atrial septal defect device closure-early symp- tomatic improvement may not predict outcome. Heart Lung Circ. 2010;19:713 6. S4.4.6.1-9. Van De Bruaene A, Delcroix M, Pasquet A, et al. The importance of pulmonary artery pressures on late atrial arrhythmia in trans- catheter and surgically closed ASD type secundum. Int J Cardiol. 2011;152:192 5. S4.4.6.1-10. Van De Bruaene A, Moons P, Belmans A, et al. Predictive model for late atrial arrhythmia after closure of an atrial septal defect. Int J Cardiol. 2013;164:318 22. S4.4.6.1-11. Berner M, Beghetti M, Spahr-Schopfer I, et al. Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congen- ital heart disease. Am J Cardiol. 1996;77:532 5. S4.4.6.1-12. Balint OH, Samman A, Haberer K, et al. Outcomes in patients with pulmonary hypertension undergoing percutaneous atrial septal defect closure. Heart. 2008;94:1189 93. S4.4.6.1-13. 